@article {1176, title = {Case-Control Study Examining the Composition of the Gut Microbiome in Individuals With and Without Immune-Mediated Dry Eye.}, journal = {Cornea}, year = {2022}, month = {2022 Dec 13}, abstract = {

PURPOSE: Gut microbiome alterations have been associated with various autoimmune diseases. There are limited data, however, on relationships between gut dysbiosis and immune-related dry eye (DE). Our aim was to compare the gut microbiome composition of individuals with early and late markers of Sj{\"o}gren syndrome (SS) with controls without DE.

METHODS: We compared 20 individuals with positive early markers [antisalivary protein 1 (SP1), antiparotid secretory protein (PSP), anticarbonic anhydrase 6 (CA6) IgG, IgA, and IgM, n = 19)], or late markers (anti-Ro/SS-A and anti-La/SS-B, n = 1) of SS with no comorbid autoimmune diagnoses and 20 age-matched and sex-matched controls. Collected stool samples underwent deep RNA sequencing. The main outcomes measured included gut microbiome composition and diversity.

RESULTS: A total of 20 cases [Dry Eye Questionnaire-5 15.2 {\textpm} 3.4, Ocular Surface Disease Index 55.1 {\textpm} 22.8, and Schirmer 7.1 {\textpm} 5.2 mm] were compared with 20 controls (Dry Eye Questionnaire-5 4.8 {\textpm} 3.8, Ocular Surface Disease Index 14.2 {\textpm} 12.3, and Schirmer 20.4 {\textpm} 9.2 mm). No differences were observed in α-diversity (P = 0.97) or overall community structure (P = 0.62). Between groups, 32 species were differentially abundant (P \< 0.01). Among cases, 27 were relatively more abundant, including 10 Lactobacillus and 4 Bifidobacterium species. A relative depletion of 5 species was found in cases compared with controls, notably Fusobacterium varium and Prevotella stercorea.

CONCLUSIONS: Differences in gut microbiome composition were found in individuals with mostly early markers of SS compared with controls. However, their clinical significance to DE manifestations remains unclear. Further studies are needed to elucidate the role of gut dysbiosis on immune dysregulation and disease activity in the various forms of immune-mediated DE.

}, issn = {1536-4798}, doi = {10.1097/ICO.0000000000003195}, author = {Goodman, Courtney F and Doan, Thuy and Mehra, Divy and Betz, Jason and Locatelli, Elyana and Mangwani-Mordani, Simran and Kalahasty, Karthik and Hernandez, Mireya and Hwang, Jodi and Galor, Anat} }